Abstract: An insertion device is configured to access a disc positioned between adjacent vertebrae. The insertion device includes a cannula having a passage formed therein. The cannula has an exit aperture. An obturator is substantially positioned within the passage formed in the cannula. One end of the obturator has a probe and the other end of the obturator has a head. An impaction cap is in contact with the cannula and is positioned to cover the head of the obturator. The impaction cap is configured to allow at least a portion of the cannula to be inserted through a portion of one vertebra without deployment of the probe of the obturator through the exit aperture of the cannula.
Abstract: A photovoltaic cell structure is disclosed that includes a back contact layer that includes single wall carbon nanotube elements. The single wall carbon nanotube (SWNT) back contact is in electrical communication with an adjacent semiconductor layer and provides a buffer characteristic that impedes elemental metal migration from the back contact into the semiconductor active layers. In one embodiment, the SWNT back contact includes a semiconductor characteristic and a buffer characteristic. In another embodiment, the SWNT back contact further includes a metallic characteristic.
Type:
Application
Filed:
August 13, 2013
Publication date:
August 6, 2015
Applicant:
The University of Toledo
Inventors:
Michael J. Heben, Adam B. Phillips, Rajendra R. Khanal, Victor V. Plotnikov, Alvin D. Compaan
Abstract: A multifunctional neural network system for prediction which includes memory components to store previous values of data within a network. The memory components provide the system with the ability to learn relationships/patterns existent in the data over time.
Abstract: The present invention provides materials and methods to induce cell death by methuosis, a non-apoptotic cell death mechanism, to induce vacuolization without cell death, or to induce cell death without vacuolization. Small molecules herein are useful for treating cell proliferation disorders or anomalies, particularly, but not exclusively, cancer. Methods related to the research and pharmaceutical use of the small molecules are also provided herein.
Type:
Grant
Filed:
February 6, 2015
Date of Patent:
June 23, 2015
Assignee:
The University of Toledo
Inventors:
William A. Maltese, Paul W. Erhardt, Jean H. Overmeyer, Christopher Trabbic
Abstract: A desulfurizer-reformer reactor system comprising a gradient assembly having a de-sulfurizing material and a reforming catalyst material arranged in a sequential manner and methods of generating energy are disclosed.
Abstract: The present invention provides materials and methods to induce cell death by methuosis, a non-apoptotic cell death mechanism, to induce vacuolization without cell death, or to induce cell death without vacuolization. Small molecules herein are useful for treating cell proliferation disorders or anomalies, particularly, but not exclusively, cancer. Methods related to the research and pharmaceutical use of the small molecules are also provided herein.
Type:
Application
Filed:
February 6, 2015
Publication date:
June 4, 2015
Applicant:
The University of Toledo
Inventors:
William A. Maltese, Paul W. Erhardt, Jean H. Overmeyer, Christopher Trabbic
Abstract: The present invention provides materials and methods to induce cell death by methuosis, a non-apoptotic cell death mechanism. Small molecules herein are useful for treating cell proliferation disorders or anomalies, particularly, but not exclusively, cancer. Methods related to the research and pharmaceutical use of the small molecules are also provided herein.
Type:
Grant
Filed:
February 24, 2012
Date of Patent:
May 12, 2015
Assignee:
The University of Toledo
Inventors:
William A. Maltese, Paul W. Erhardt, Michael W. Robinson, Jean H. Overmeyer
Abstract: The present invention provides materials and methods to induce cell death by methuosis, a non-apoptotic cell death mechanism, to induce vacuolization without cell death, or to induce cell death without vacuolization. Small molecules herein are useful for treating cell proliferation disorders or anomalies, particularly, but not exclusively, cancer. Methods related to the research and pharmaceutical use of the small molecules are also provided herein.
Type:
Grant
Filed:
April 7, 2014
Date of Patent:
May 5, 2015
Assignee:
The University of Toledo
Inventors:
William A. Maltese, Paul W. Erhardt, Christopher Trabbic, Jean H. Overmeyer
Abstract: The present invention provides materials and methods related to culturing stable Treg cells or in vivo expansion of stable Treg cells, the cells made by the methods, treatments for various inflammatory/autoimmune pathologies and transplant/graft rejection, and related materials. Ex vivo induction and expansion of the stable Tregs is described, including use of inducing compositions, such as certain mAbs and other compounds, along with expansion medium comprising IL-2. In vivo expansion of stable Treg cells and treatments for various inflammatory/autoimmune pathologies and transplant/graft rejection are described, including the use of mAbs and their variants.
Type:
Grant
Filed:
July 25, 2011
Date of Patent:
April 28, 2015
Assignee:
The University of Toledo
Inventors:
Stanislaw M. Stepkowski, Wenhao Chen, Yoshihiro Miyahara
Abstract: Formulations having, as active agents, at least one quaternized polymeric microgel and at least one surfactant, methods of making, and methods of using are described.
Abstract: The present invention is directed to methods and compositions for evaluating nucleic acids, methods of preparing such compositions, and applications and business methods employing such compositions and methods. In particular, the present invention provides business methods for operating a gene expression measurement service.
Type:
Grant
Filed:
March 16, 2009
Date of Patent:
March 17, 2015
Assignees:
Gene Express, Inc., University of Toledo
Inventors:
James C. Willey, Brad Austermiller, Erin L. Crawford, Charles Knight, Terry Osborn, Robert Zahorchak
Abstract: A method for regulating Src and its downstream signaling pathway which includes binding between Src and Na+/K+-ATPase is disclosed. The Na+/K+-ATPase/Src complex is a functional receptor for cardiotonic steroids such as ouabain. Also disclosed are Src inhibitors or activators which include either Na+/K+-ATPase or Src that interfere with the interaction between the Na/K-ATPase and Src, act via a different mechanism from ATP analogs, and is pathway (Na+/K+-ATPase) specific.
Type:
Grant
Filed:
September 24, 2012
Date of Patent:
March 17, 2015
Assignee:
The University of Toledo
Inventors:
Zi-Jian Xie, Joseph I. Shapiro, Jiang Tian, Zhichuan Li
Abstract: A system is provided for use in brachytherapy where a central tube permits passage of a radioactive source therethrough to deliver a prescribed dosage of radiation. One or more balloons are coaxially positioned around the central tube. At least one balloon includes one or more peripheral tubes extending along at least a portion of the balloon. The peripheral tube is also attached to the high dose rate brachytherapy unit in order to permit passage of a radioactive source therethrough.
Abstract: This invention relates to an improved structure for an interspinous stabilization device that more evenly distributes loads throughout the adjacent vertebrae than known interspinous stabilization devices, and further readily compensates for graft settling so as to maintain continued axial loading of the graft. More specifically, this invention relates to a medical device that helps in performing a spinal fusion procedure by holding the bone graft in place and stabilizing the facet screw by a plate that is attached to it. The invention also performs a dynamic function that compensates for settling of the bone graft over time. This dynamic function may, if desired, be enhanced by a movement-limiting mechanism that allows extension but not flexion such that the bone graft fusion remains in contact and fusion takes place.
Type:
Application
Filed:
February 19, 2013
Publication date:
January 8, 2015
Applicant:
The University of Toledo
Inventors:
Anand K. Agarwal, Vijay K. Goel, Aakash Agarwal
Abstract: An inter-vertebral cage for use in repairing a damaged inter-vertebral disc includes a plurality of cage sections and a hinge element that connects adjacent ones of the cage sections together for relative movement. The hinge elements automatically urge the cage sections to move from an extended orientation to an installed orientation.
Type:
Application
Filed:
September 20, 2012
Publication date:
December 25, 2014
Applicant:
The University of Toledo
Inventors:
Mohammad Elahinia, Anand Agarwal, Vijay Goel, Walter Anderson, Cory Chapman
Abstract: A noninvasive method and apparatus for determining analyte concentration (e.g., glucose) in a subject that includes measuring light refraction from at least a portion one or more structures. One example of such structure is the subject's iris.
Abstract: This process relates to a pharmaceutical composition of an Na—K-ATPase ligand which will stimulate Na/K-ATPase signaling in a pharmaceutically acceptable vehicle. In one embodiment, the composition may be used to treat a skin disorder. In another embodiment, the composition may be used to inhibit cardiac fibrosis.